Disease Course and Treatment Responses in Children With RelapsingMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

Hacohen, Yael; YiWong, Yu; Lechner, Christian; Jurynczyk, Maciej; Wright, Sukhvir; KONUŞKAN, BAHADIR; Kalser, Judith; Poulat, Anne; Maurey, Helene; Ganelin-Cohen, Esther; Wassmer, Evangeline; Hemingway, Chery; Forsyth, Rob; Hennes, Eva; Leite, Isabel; Ciccarelli, Olga; Anlar, Banu; Hintzen, Rogier; Marignier, Romain; Palace, Jacqueline; Baumann, Matthias; Rostasy, Kevin; Neuteboom, Rinze; Deiva, Kumaran; Lim, Ming

doi:10.1001/jamaneurol.2017.4601

Disease Course and Treatment Responses in Children With RelapsingMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

Hacohen Y., YiWong Y., Lechner C., Jurynczyk M., Wright S., KONUŞKAN B., ...More

JAMA NEUROLOGY, vol.75, no.4, pp.478-487, 2018 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 75 Issue: 4
Publication Date: 2018
Doi Number: 10.1001/jamaneurol.2017.4601
Journal Name: JAMA NEUROLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.478-487
Open Archive Collection: AVESIS Open Access Collection
Hacettepe University Affiliated: Yes

Abstract

IMPORTANCE Myelin oligodendrocyte glycoprotein antibodies (MOG-Abs) are consistently identified in a range of demyelinating disorders in adults and children. Current therapeutic strategies are largely center specific, and no treatments have been formally evaluated.